Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/21048157

Blood 2011 Jan 13 117 2 510-8

Download in:

View as

General Info

PMID
21048157